Skip to main content
Ascendis Pharma A/S logo

Ascendis Pharma A/S — Investor Relations & Filings

Ticker · ASND ISIN · US04351P1012 LEI · 549300B66JN3W3J8GH73 US Manufacturing
Filings indexed 714 across all filing types
Latest filing 2026-05-07 Foreign Filer Report
Country DK Denmark
Listing US ASND

About Ascendis Pharma A/S

https://ascendispharma.dk/

Ascendis Pharma is a biopharmaceutical company that applies its proprietary TransCon (Transient Conjugation) technology platform to develop new therapies. The company's focus is on addressing unmet medical needs in rare diseases, with primary therapeutic areas in endocrinology and oncology. The TransCon technology is designed to create prodrugs that provide a predictable and sustained release of an unmodified parent drug, aiming to improve treatment outcomes for patients. Through this platform, Ascendis Pharma is advancing a pipeline of product candidates and is building a fully integrated biopharmaceutical organization.

Recent filings

Filing Released Lang Actions
6-K - Ascendis Pharma A/S (0001612042) (Filer)
Foreign Filer Report
2026-05-07 English
6-K - Ascendis Pharma A/S (0001612042) (Filer)
Foreign Filer Report
2026-05-07 English
6-K - Ascendis Pharma A/S (0001612042) (Filer)
Foreign Filer Report
2026-04-21 English
6-K - Ascendis Pharma A/S (0001612042) (Filer)
Foreign Filer Report
2026-04-20 English
6-K - Ascendis Pharma A/S (0001612042) (Filer)
Foreign Filer Report
2026-04-08 English
6-K - Ascendis Pharma A/S (0001612042) (Filer)
Foreign Filer Report
2026-04-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.